Free Trial

CenterBook Partners LP Makes New Investment in Core Scientific, Inc. (NASDAQ:CORZ)

Core Scientific logo with Finance background
Remove Ads

CenterBook Partners LP acquired a new position in shares of Core Scientific, Inc. (NASDAQ:CORZ - Free Report) during the 4th quarter, according to its most recent filing with the SEC. The institutional investor acquired 99,071 shares of the company's stock, valued at approximately $1,392,000.

Several other institutional investors also recently bought and sold shares of CORZ. Xponance Inc. boosted its position in Core Scientific by 7.9% during the 4th quarter. Xponance Inc. now owns 12,800 shares of the company's stock worth $180,000 after acquiring an additional 937 shares during the period. Wellington Shields & Co. LLC acquired a new position in Core Scientific during the 4th quarter worth $26,000. First Horizon Advisors Inc. bought a new stake in shares of Core Scientific in the fourth quarter valued at approximately $34,000. Joel Isaacson & Co. LLC boosted its position in shares of Core Scientific by 4.5% during the 4th quarter. Joel Isaacson & Co. LLC now owns 58,011 shares of the company's stock valued at $815,000 after acquiring an additional 2,500 shares in the last quarter. Finally, Newbridge Financial Services Group Inc. bought a new stake in shares of Core Scientific in the 4th quarter worth about $42,000.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently commented on the stock. Compass Point lowered their price target on shares of Core Scientific from $26.00 to $20.00 and set a "buy" rating for the company in a research report on Tuesday, February 25th. Keefe, Bruyette & Woods started coverage on Core Scientific in a report on Monday, January 27th. They issued an "outperform" rating and a $22.00 price objective on the stock. Cantor Fitzgerald decreased their target price on Core Scientific from $24.00 to $21.00 and set an "overweight" rating on the stock in a research report on Thursday, February 27th. Needham & Company LLC cut their price objective on Core Scientific from $18.00 to $17.00 and set a "buy" rating on the stock in a research note on Thursday, February 27th. Finally, HC Wainwright reaffirmed a "buy" rating and issued a $17.00 target price on shares of Core Scientific in a research report on Tuesday, March 11th. Fifteen research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, Core Scientific has a consensus rating of "Buy" and an average target price of $19.07.

Remove Ads

View Our Latest Report on Core Scientific

Core Scientific Price Performance

NASDAQ CORZ traded down $0.05 on Wednesday, hitting $6.80. The company had a trading volume of 2,974,882 shares, compared to its average volume of 12,353,374. The company has a market capitalization of $2.01 billion, a PE ratio of -1.26 and a beta of 6.80. The company's fifty day moving average price is $9.16 and its 200-day moving average price is $12.65. Core Scientific, Inc. has a 12-month low of $2.61 and a 12-month high of $18.63.

Core Scientific (NASDAQ:CORZ - Get Free Report) last released its quarterly earnings results on Wednesday, February 26th. The company reported ($0.01) EPS for the quarter, beating the consensus estimate of ($0.10) by $0.09. The firm had revenue of $94.93 million for the quarter, compared to analysts' expectations of $97.07 million. On average, sell-side analysts anticipate that Core Scientific, Inc. will post 0.52 EPS for the current year.

Insider Buying and Selling at Core Scientific

In other Core Scientific news, Director Todd A. Becker sold 134,250 shares of the business's stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $10.75, for a total transaction of $1,443,187.50. Following the sale, the director now directly owns 195,687 shares in the company, valued at approximately $2,103,635.25. The trade was a 40.69 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Todd M. Duchene sold 25,277 shares of the firm's stock in a transaction dated Friday, January 24th. The stock was sold at an average price of $16.24, for a total transaction of $410,498.48. Following the completion of the transaction, the insider now owns 2,023,423 shares of the company's stock, valued at approximately $32,860,389.52. The trade was a 1.23 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders sold 530,041 shares of company stock worth $7,870,352. 32.00% of the stock is owned by insiders.

Core Scientific Company Profile

(Free Report)

Core Scientific, Inc provides digital asset mining services in North America. It operates through two segments, Mining and Hosting. The company offers blockchain infrastructure, software solutions, and services; and operates data center mining facilities. It also mines digital assets for its own account; and provides hosting services for other large bitcoin miners, which include deployment, monitoring, trouble shooting, optimization, and maintenance of its customers' digital asset mining equipment.

Recommended Stories

Institutional Ownership by Quarter for Core Scientific (NASDAQ:CORZ)

Should You Invest $1,000 in Core Scientific Right Now?

Before you consider Core Scientific, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Core Scientific wasn't on the list.

While Core Scientific currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

5 Stocks to BUY Now as Tariff Uncertainty Fades
WWE Stock Could Explode Next Week — Now’s the Time to Buy Into TKO
These 3 Dividend Stocks Might Be the Safest Bet Right Now

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads